| Bioactivity | (Rac)-MEM 1003 is the racemate of MEM 1003. MEM 1003, a dihydropyridine compound, is a potent L-type Ca2+ channel antagonist and has the potential for Alzheimer’s disease research[1]. | ||||||||||||
| Name | (Rac)-MEM 1003 | ||||||||||||
| CAS | 165187-25-7 | ||||||||||||
| Formula | C22H25ClN2O5 | ||||||||||||
| Molar Mass | 432.90 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Gregory M Rose, et al. Efficacy of MEM 1003, a novel calcium channel blocker, in delay and trace eyeblink conditioning in older rabbits. Neurobiol Aging. 2007 May;28(5):766-73. |
(Rac)-MEM 1003
CAS: 165187-25-7 F: C22H25ClN2O5 W: 432.90
(Rac)-MEM 1003 is the racemate of MEM 1003. MEM 1003, a dihydropyridine compound, is a potent L-type Ca2+ channel antago
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.